Treatment of Moderate to Severe Lateral Canthal Lines and Glabellar Lines Alone or in Combination
Treatment of Moderate to Severe Lateral Canthal Lines and Glabellar Lines Alone or in Combination
This study is designed to evaluate the safety and efficacy of a single dose of QM1114-DP for
 the treatment of moderate to severe LCL and moderate to severe GL, alone or in combination.
Inclusion Criteria:

 1. Male or female 18 years of age or older.

 2. Moderate to severe LCL at maximum smile as assessed by the Investigator.

 3. Moderate to severe LCL at maximum smile as assessed by the subject.

 4. Moderate to severe GL at maximum frown as assessed by the Investigator.

 5. Moderate to severe GL at maximum frown as assessed by the subject

 Exclusion Criteria:

 1. Previous use of any Botulinum toxin in facial areas within 9 months prior to study
 treatment.

 2. Female who is pregnant, breast feeding, or intends to conceive a child during the
 study.

 3. Known allergy or hypersensitivity to any component of the investigational product
 (QM1114-DP).